NAFDAC Approves Use Of Chloroquine For Early Stage COVID-19 Patients

NAFDAC Approves Use Of Chloroquine For Early Stage COVID-19 Patients



4 years ago

~1.6 mins read

Advertisement

Naija News Understands that Mojisola Adeyeye, director-general of NAFDAC  while speaking  on Tuesday during a virtual news conference in Abuja, stated research has shown that chloroquine is effective for the treatment of COVID-19 at the early stage of infection.

She also revealed that chloroquine can be used prophylactically and that countries like Ghana and Senegal have also embraced the clinical use of chloroquine for treatment.

She added that it is not only one drug that is effective for COVID-19 treatment but that it depends on the stage and the phases of the disease.

"On March 20, this year, I had a press briefing.

Admin Sponsored

Make money posting ads on your blog

Generate passive income with your blog, website or social media. Join Adsterra

Cinque Terre
At that time, people did not understand what clinical trial treatment meant.

Advertisement

Once they hear treatment, they think you can use it anyhow. But clinical trial treatment is a research study to see whether the drug will work or not.

"In the press briefing, I said I was going through literature to see what others have done and I saw in a particular literature, a reliable publication of an article, about chloroquine and remdesivir.

.

Was my post useful? Support me to keep creating useful content

Disclaimer If this post is your copyrighted property, please message this user or email us your request at team@pejoweb.com with a link to this post




1 like
 

Advertisement

";

Advertisement